Oral fexinidazole for stage 1 or early stage 2 African Trypanosoma brucei gambiense trypanosomiasis: a prospective, multicentre, open-label, cohort study.

Kande Betu Ku Mesu V, Mutombo Kalonji W, Bardonneau C, Valverde Mordt O, Ngolo Tete D, Blesson S, Simon F, Delhomme S, Bernhard S, Mahenzi Mbembo H, Mpia Moke C, Lumeya Vuvu S, Mudji E'kitiak J, Akwaso Masa F, Mukendi Ilunga M, Mpoyi Muamba Nzambi D, Mayala Malu T, Kapongo Tshilumbwa S, Botalema Bolengi F, Nkieri Matsho M, Lumbala C, Scherrer B, Strub-Wourgaft N, Tarral A.

Open source

DOI: 10.1016/s2214-109x(21)00208-4
Published: 2021-07-01
Container: Lancet Glob Health
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/s2214-109x-21-00208-4,
  title = {Oral fexinidazole for stage 1 or early stage 2 African Trypanosoma brucei gambiense trypanosomiasis: a prospective, multicentre, open-label, cohort study.},
  author = {Kande Betu Ku Mesu V and  Mutombo Kalonji W and  Bardonneau C and  Valverde Mordt O and  Ngolo Tete D and  Blesson S and  Simon F and  Delhomme S and  Bernhard S and  Mahenzi Mbembo H and  Mpia Moke C and  Lumeya Vuvu S and  Mudji E'kitiak J and  Akwaso Masa F and  Mukendi Ilunga M and  Mpoyi Muamba Nzambi D and  Mayala Malu T and  Kapongo Tshilumbwa S and  Botalema Bolengi F and  Nkieri Matsho M and  Lumbala C and  Scherrer B and  Strub-Wourgaft N and  Tarral A.},
  year = {2021},
  journal = {Lancet Glob Health},
  doi = {10.1016/s2214-109x(21)00208-4},
  url = {https://doi.org/10.1016/s2214-109x(21)00208-4}
}

RIS

TY  - JOUR
TI  - Oral fexinidazole for stage 1 or early stage 2 African Trypanosoma brucei gambiense trypanosomiasis: a prospective, multicentre, open-label, cohort study.
AU  - Kande Betu Ku Mesu V
AU  -  Mutombo Kalonji W
AU  -  Bardonneau C
AU  -  Valverde Mordt O
AU  -  Ngolo Tete D
AU  -  Blesson S
AU  -  Simon F
AU  -  Delhomme S
AU  -  Bernhard S
AU  -  Mahenzi Mbembo H
AU  -  Mpia Moke C
AU  -  Lumeya Vuvu S
AU  -  Mudji E'kitiak J
AU  -  Akwaso Masa F
AU  -  Mukendi Ilunga M
AU  -  Mpoyi Muamba Nzambi D
AU  -  Mayala Malu T
AU  -  Kapongo Tshilumbwa S
AU  -  Botalema Bolengi F
AU  -  Nkieri Matsho M
AU  -  Lumbala C
AU  -  Scherrer B
AU  -  Strub-Wourgaft N
AU  -  Tarral A.
PY  - 2021
JO  - Lancet Glob Health
DO  - 10.1016/s2214-109x(21)00208-4
UR  - https://doi.org/10.1016/s2214-109x(21)00208-4
ER  -

APA

V, K. B. K. M., W, M. K., C, B., O, V. M., D, N. T., S, B., F, S., S, D., S, B., H, M. M., C, M. M., S, L. V., J, M. E., F, A. M., M, M. I., D, M. M. N., T, M. M., S, K. T., F, B. B., M, N. M., C, L., B, S., N, S., & A., T. (2021). Oral fexinidazole for stage 1 or early stage 2 African Trypanosoma brucei gambiense trypanosomiasis: a prospective, multicentre, open-label, cohort study.. Lancet Glob Health. https://doi.org/10.1016/s2214-109x(21)00208-4

Source records

europe-pmc · retrieved 2026-09-27T13:22:42.843Z
doaj · retrieved 2026-09-27T13:22:42.836Z